906
Views
35
CrossRef citations to date
0
Altmetric
Review Article

Eosinophilic diseases of the gastrointestinal tract

Pages 1013-1021 | Received 05 Nov 2009, Accepted 08 Feb 2010, Published online: 31 May 2010

References

  • Behm CA, Ovington KS. The role of eosinophils in parasitic helminth infections: insights from genetically modified mice. Parasitol Today 2000;16:202–9.
  • Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol 1986;39:177–253.
  • Weller PF, Lim K, Wan HC, Dvorak AM, Wong DT, Cruikshank WW, Role of the eosinophil in allergic reactions. Eur Respir J Suppl 1996;22:109s–115s.
  • Butterworth AE. Cell-mediated damage to helminths. Adv Parasitol 1984;23:143–235.
  • Rothenberg ME, Mishra A, Brandt EB, Hogan SP. Gastroeintestinal eosinophils. Immunol Rev 2001;179:139–55.
  • Rothenberg ME. Eosinophilic gastrointestinal disorders. J Allergy Clin Immunol 2004;113:11–28.
  • Winter HS, Madara JL, Stafford RJ, Grand RJ, Quinlan JE, Goldman H. Intraepitelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology 1982;83:818–23.
  • Brown LF, Goldman H, Antonioli DA. Intraepitelial eosinophils in endoscopic biopsies of adults with reflux esophagitis. Am J Surg Pathol 1984;8:899–905.
  • Walsh RE, Gaginella TS. The eosinophil in inflammatory bowel disease. Scand J Gastroeneterol 1991;1217–24.
  • Dvorak AM. Ultrastructural evidence for release of major basic protein-containing crystaline cores of eosinophil granules in vivo: cytotoxic potential in Cronh's disease. J Immunol 1980;125:462.
  • Sarin SK, Malhotra V, Sen Gupta S, Karol A, Gaur SK, Anand BS. Significant eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sci 1978;32:363–7.
  • Desreumaux P, Nutten S, Colombel JF. Activated eosinophils in inflammatory bowel disease: do they matter? Am J Gastroenterol 1999;94:189–95.
  • Nishitani H, Okabayashi M, Satomi M, Shimoyama T, Dohi Y. Infiltration of peroxidase-producing eosinophils into the lamina propria of patients with ulcerative colitis. J Gastroenterol 1998;33:189–95.
  • Mueller S. Classification of eosinophilic gastrointestinal diseases. Best Pract Res Clin Gastroenterol 2008;22:425–40.
  • Kaijser R. Zur Kenntnis der allergischen Affektioner desima Verdeanungaskanal von Standpunkt desmia Chirurgen aus. Arch Klin Chir 1937;188:36–64.
  • Furuta GT, Forbes D, Boey C, Dupont C, Putnam P, Roy SK, Eosinophilic Gastrointestinal Diseases Working Group. Eosinophilic gastrointestinal diseases (EGIDs). J Pediatr Gastroenterol Nutr 2008;47:234–8.
  • Cherian S, Smith NM, Forbes DA. Rapidily increasing prevalence of eosinophilic esophagitis in Western Australia. Arch Dis Child 2006;91:1000–4.
  • Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E, Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005;3;1198–206.
  • Garn H, Renz H. Epidemiological and immunological evidence for the hygiene hypothesis. Immunobiology 2007;212:441–52.
  • Weinstock JV, Elliott DE. Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis 2009;15:128–33.
  • Ronkanien J, Talley NJ, Aro P, Storskrubb T, Johansson SE, Lind T, Prevalence of esophageal eosinophils and eosinophilic esophagitis in adults: the population-based Kalixandra study. Gut 2007;56:615–20.
  • Gonsalves N. Food allergy and eosinophilic gastrointestinal illness. Gastroenterology Clin North Am 2007;36:75–91.
  • Pratt CA, Demain JG, Rathkopf MM. Food allergy and eosinophilic gastrointestinal disorders: guiding our diagnosis and treatment. Curr Probl Pediatr Adolesc Health Care 2008;38:170–88.
  • Almansa C, Krishna M, Buchner AM, Ghabril MS, Talley N, DeVault KR, Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol 2009;104:828–33.
  • Spergel JM, Andrews T, Brown-Whitehorn TF, Beausoleil JL, Liacouras CA. Treatment of eosinophilic esophagitis with specific elimination diet directed by a combination of skin prick and patch test. Ann Allergy Asthma Immunol 2005;95:336–43.
  • Collins MH, Blanchard C, Albonia JP, Kirby C, Akers R, Wang N, Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin Gastroenterol Hepatol 2008;6:621–9.
  • Spechler SJ, Genta RM, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol 2007;102:1301–6.
  • Merwat SN, Spechler SJ. Might the use of acid-suppressive medications predispose to the development of eosinophilic esophagitis? Am J Gastroenterol 2009;104:1902.
  • Mishra A, Hogan SP, Brandt EB, Rothenberg ME. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol 2002;168:2464–9.
  • Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 2003;125:1419–27.
  • Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006;116:536–47.
  • Lucendo AJ, De Rezende L, Comas C, Caballero T, Bellon T. Treatment With topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis. Am J Gastroenterol 2008;103:2184–93.
  • Hogan SP, Rothenberg ME, Forbes E, Smart VE, Matthaei KI, Foster PS. Chemokines in eosinophil-associated gastrointestinal disorders. Curr Allergy Asthma Rep 2004;4:74–82.
  • Aceves SS, Newbury RO, Dohil R, Bastian JF, Broide DH. Esophageal remodeling in paediatric eosinophilic esophagitis. J Allergy Clin Immunol 2007;119:206–12.
  • Lee R. Marked eosinophilia in esophageal mucosal biopsies. Am J Surg Pathol 1985;7:479.
  • Ruchelli E, Wenner W, Voytek T, Brown K, Liacouras C. Severity of esophageal eosinophilia predict response to conventional gastroesophageal reflux therapy. Pediatr Dev Pathol 1999;2:15–18.
  • Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995;109:1503–12.
  • Attwood SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 1993;38:109–16.
  • Liacouras CA, Bonis P, Putman PE, Straumann A, Ruchelli E, Gupta SK, Summary of the first international gastrointestestinal eosinophil research symposium. J Pediatr Gastroenterol Nutr 2007;45:370–91.
  • Liacouras C. Eosinophilic esophagitis in children and adults. J Pediatr Gastroenterol Nutr 2003;37:S23–8.
  • Lucendo Villarín AJ, De Rezende L. Eosinophilic esophagitis. Review of current clinical and physiopathological concepts. Gastroenterol Hepatol 2007;30:234–41.
  • Molina-Infante J, Hernández-Alonso M, Pérez-Gallardo B, Martin-Noguerol E. The first Asian case report of eosinophilic esophagitis in an asymptomatic adult: what about a proton pump inhibitor trial? J Chin Med Assoc 2009;72:166–7.
  • Noel RJ, Putman PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med 2001;26:940–1.
  • Lucendo AJ, Pascual-Turrión JM, Navarro M, Comas C, Castillo P, Letrán A, Endoscopic, bioptic and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series. Endoscopy 2007;39:765–71.
  • Mueller S, Aigner T, Neureiter D, Stolte M. Eosinophil infiltration and degranulation in esophageal mucosa from adult patients with eosinophilic esophagitis (EE). A retrospective comparative pathologic biopsy study. J Clin Pathol 2006; DOI:10.1136/jcp.2005.031922.
  • Lucendo Villarin AJ. Eosinophilic esophagitis – clinical manifestations, diagnosis, and treatment. Rev Esp Enferm Dig 2009;101:49–59.
  • Dellon ES, Aderroju A, Woosley JT, Sandler RS, Shaheen NJ. Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol 2007;102:1–14.
  • Freeman HJ. Adult eosinophilic gastroenteritis and hypereosinophilic syndromes. Wordl J Gastroenterol 2008;14:6771–3.
  • Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 1990;31:58.
  • Yun MY, Cho YU, Park IS, Choi SK, Kim SJ, Shin SH, Eosinophilic gastroenteritis presenting as small bowel obstruction: a case report and review of the literature. World J Gastroenterol 2007;13:1758–60.
  • Katz AJ, Twarog FJ, Zeiger RS, Falchuk ZM. Milk-sensitive and eosinophilic gastroenteropathy: similar clinical features with contrasting mechanisms and clinical course. J Allergy Clin Immunol 1984;74:72–8.
  • Navajas Leon FJ, Lucendo Villarin AJ, Erdozain Sosa JC, Carrion Alonso G, Martin Chavarri S, Gomez Senent S, Eosinophilia and actinic enteritis due to radiotherapy for prostatic adenocarcinoma. Rev Esp Enferm Dig 2005;97:759–61.
  • Carvalho AT, Elia CC, de Souza HS, Elias PR, Pontes EL, Lukashok HP, Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease. J Clin Gastroenterol 2003;36:79–94.
  • Jeziorska M, Haboubi N, Schofield P, Woolley DE. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique. J Pathol 2001;194:484–92.
  • Rubin M. Allergic intestinal bleeding in the newborn. Am J Med Sci 1940;200.
  • Boné J, Claver A, Guallar I. Proctocolitis alérgica, enterocolitis inducida por alimento: mecanismos immunes, diagnóstico y tratamiento. Allergol Immunopathol (Madr) 2008;36 (suppl 1):25–31.
  • Kilshaw PJ, Cant AJ. The passage of maternal dietary proteins into human breast milk. Int Arch Allergy Appl Immunol 1984;75:8–15.
  • Machida HM, Catto-Smith AG, Gall DG, Trevenen C, Scott RB. Allergic colitis in infancy: clinical and pathological aspects. J Pediatr Gastroenterol Nutr 1994;19:26.
  • Sicherer SH, Eigenmann PA, Sampson HA. Clinical features of food protein-induced enterocolitis syndrome. J Pediatr 1998;133:219.
  • Chusid MJ, Dale DC, West BC, Wolf SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975;54:1–27.
  • Anderson RE, Hardy WR. Hypereosinophilia. Ann Intern Med 1968;69:1331–2.
  • Straumann A. Idiopathic eosinophilic gastrointestinal diseases in adults. Best Pract Res Clin Gastroenterol 2008;22:496.
  • Klion AD, Noel P, Akin C, Law MA, Gilliland DG, Cools J, Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 2003;101:4660–6.
  • Klion AD. Recent advances in the diagnosis and treatment of hypereosinophilic syndromes. Hematology Am Soc Hematol Educ Program 2005;209–14.
  • Klion AD, Robyn JA, Akin C, Noel P, Brown M, Law M, Molecular remision and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood 2004;103:473–8.
  • Stone KD, Prussin C. Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases. Clin Exp Allergy 2008;38:1858–65.
  • Peterson KA, Thomas KL, Hilden K, Emerson LL, Wills JC, Fang JC. Comparasion of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci 2009, in press.
  • Konikoff MR, Noel RJ, Blanchard C, Kirby C, Jameson SC, Buckmeier BK, A randomized double-blind, placebo controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006;131:1381–91.
  • Ngo P, Furuta GT. Treatment of eosinophilic esophagitis in children. Curr Treat Options Gastroenterol 2005;8:397–403.
  • Kagalwalla AF, Sentongo TA, Ritz S, Hess T, Nelson SP, Emerick KM, Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol 2006;119:1097–102.
  • Gonsalves N, Ritz S, Yang G, Ditto A, Hirano I. A prospective clinica trial of allergy testing and food elimination diet in adults with eosinophilic esophagitis (EE). Gastroenterology 2007;132 suppl 1, A6–7.
  • Chen MJ, Chu CH, Lin SC, Shih SC, Wang TE. Eosinophilic gastroenteritis: clinical experience with 15 patients. World J Gastroenterol 2003;9:2813–6.
  • Schaefer ET, Fitzgerald JF, Molleston JP, Croffie JM, Pfefferkorn MD, Corkins MR, Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol 2008;6:165–73.
  • Aceves SS, Dohil R, Newbury RO, Bastian JF. Topical viscous budesonide suspension for treatment of eosinophilic esophagitis. J Allergy Clin Immunol 2005;116:705–6.
  • Netzer P, Gschossmann JM, Straumann A, Sendensky A, Weimann R, Schoepfer AM. Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission. Eur J Gastroenterol Hepatol 2007;19:865–9.
  • Moots RJ, Prouse P, Gumpel JM. Near fatal eosinophilic gastroenteritis responded to oral sodium cromoglycate. Gut 1988;29:1282–5.
  • Pérez-Millán A, Martín-Lorente JL, López-Morante A, Yuguero L, Sáez-Royuela F. Subserosal eosinophilic gastroenteritis treated efficaciously with sodium cromoglicate. Dig Dis Sci 1997;42:342–4.
  • Melamed I, Feanny SJ, Sherman PM, Roifman CM. Benefit of ketotifen in patients with eosinophilic gastroenteritis. Am J Med 1991;90:31014.
  • Suzuki J, Kawasaki Y, Nozawa R, Isome M, Suzuki S, Takahashi A, Oral disodium cromoglycate and ketotifen for a patient with eosinophilic gastroenteritis, food allergy and protein-losing enteropathy. Asian Pac J Allergy Immunol 2003;21:193–7.
  • Shirai T, Hashimoto D, Suzuki K, Osawa S, Aonahata M, Chida K, Successful treatment of eosinophilic gastroenteritis with suplatast tosilate. J Allergy Clin Immunol 2001;107:924.
  • Attwood SE, Lewis CJ, Bronder CS, Morris CD, Armstrong GR, Whittam J. Eosinophilic esophagitis: a novel treatment using Montelukast. Gut 2003;52:181–5.
  • Lu E, Ballas ZK. Immunomodulation in the treatment of eosinophilic gastroenteritis. J Allergy Clin Immunol 2003;111:S262.
  • Friesen CA, Kearns GL, Andre L. Clinical efficacy and pharmacokinetics of Montelukast in dyspeptic children with duodenal eosinophilia. J Pediatr Gastroenterol Nutr 2004;28:343–51.
  • Kumar A, Teuber SS, Naguwa S, Prindiville T, Gershwin ME. Eosinophilc gastroenteritis and citrus-induced urticaria. Clin Rev Allergy Immunol 2006;30:61–70.
  • Klion AD. How I treat hypereosinophilic syndromes. Blood 2009, in press.
  • Kim YJ, Prussin C, Martin B, Law MA, Haverty TP, Nutman TB, Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700. J Allergy Clin Immunol 2004;114:1449–55.
  • Stein ML, Collins MH, Villanueva JM, Kushner JP, Putman PE, Buckmeier BK, Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 2006;118:1312–19.
  • Straumann A, Conus S, Grzonka P, Kita H, Kephart G, Bussmann C, Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomized, placebo-controlled, double-blind trial. Gut 2010;59:21–30.
  • Foroughi S, Foster B, Kim N, Bernardino LB, Scott LM, Hamilton RG, Anti-IgE treatment of eosinophilic-associated gastrointestinal disorders. J Allergy Clin Immunol 2007;120:594601.
  • Echeverría Zudaire L, Fernández Fernández S, Rayo Fernández A, Bracamonte Bermejo T, Cilleruelo Pascual ML. No eficacia de omalizumab (Xolair) en el tratamiento de un paciente con esofagitis eosinofílica. Allergol Immunopathol (Madr) 2008;36 (extraordinario 1):68–9.
  • Straumann A, Bussmann C, Conus S, Beglinger C, Simon HU. Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis. Gastroenterology 2008;122:425–7.
  • Prasad GA, Arora AS. Spontaneous perforation in the ringed esophagus. Dis Esophagus 2005;18:406–9.
  • Cohen MS, Kaufman A, Dimarino AJ Jr, Cohen S. Eosinophilic esophagitis presenting as spontaneous esophageal rupture (Boerhaave's syndrome). Clin Gastroenterol Hepatol 2007;5:A24.
  • Kaplan M, Mutlu EA, Jakate S, Bruninga K, Losurdo J, Keshavarzian A. Endoscopy in eosinophilic esophagitis: ‘feline’ esophagus and perforation risk. Clin Gastroenterol Hepatol 2003;1:433–7.
  • Zuber-Jerger I, Ratiu N, Kullman F. Long-lasting effect of endoscopic dilation of an esophageal stenosis due to eosinophilic esophagitis. J Gastrointestin Liver Dis 2006;15:167–70.
  • Roberts-Thomson IC. Gastrointestinal: Eosinophilic esophagitis. J Gastroenterol Hepatol 2005;29:1299.
  • Lucendo AJ, De Rezende L. Endoscopic dilation for treatment of eosinophilic esophagitis: a strategy with a high perforation risk. Endoscopy 2007;39:376.
  • Cohen MS, Kaufman AB, Palazzo JP, Nevin D, Dimarino AJ Jr, Cohen S. An audit of endoscopic complications in adult eosinophilic esophagitis. Clin Gastroenterol Hepatol 2007;5:1149–53.
  • Pasha SF, DiBaise JK, Kim HJ, De Petris G, Crowell MD, Fleischer DE, Patient characteristics, clinical, endoscopic, and histologic findings in adult eosinophilic esophagitis: a case series and systematic review of the medical literature. Dis Esophagus 2007;20:311–19.
  • Schoepfer AM, Gschossmann J, Scheurer U, Seibold F, Straumann A. Esophageal strictures in adult eosinophilic esophagitis: dilation is an effective and safe alternative after failure of topical corticosteroids. Endoscopy 2008;40:161–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.